These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2417207)

  • 1. Substance K and substance P differentially modulate mesolimbic and mesocortical systems.
    Deutch AY; Maggio JE; Bannon MJ; Kalivas PW; Tam SY; Goldstein M; Roth RH
    Peptides; 1985; 6 Suppl 2():113-22. PubMed ID: 2417207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective activation of mesolimbic and mesocortical dopamine metabolism in rat brain by infusion of a stable substance P analogue into the ventral tegmental area.
    Elliott PJ; Alpert JE; Bannon MJ; Iversen SD
    Brain Res; 1986 Jan; 363(1):145-7. PubMed ID: 2418910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance P modulation of the mesolimbic dopamine system.
    Kalivas P
    Prog Clin Biol Res; 1985; 192():403-8. PubMed ID: 2417255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between neuropeptides and dopamine neurons in the ventromedial mesencephalon.
    Kalivas PW
    Neurosci Biobehav Rev; 1985; 9(4):573-87. PubMed ID: 2417173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitonin gene-related peptide in the ventral tegmental area: selective modulation of prefrontal cortical dopamine metabolism.
    Deutch AY; Roth RH
    Neurosci Lett; 1987 Feb; 74(2):169-74. PubMed ID: 3554009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated administration of the neurotensin receptor antagonist SR 48692 differentially regulates mesocortical and mesolimbic dopaminergic systems.
    Azzi M; Betancur C; Sillaber I; Spanagel R; Rostène W; Bérod A
    J Neurochem; 1998 Sep; 71(3):1158-67. PubMed ID: 9721741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance K and substance P in the ventral tegmental area.
    Kalivas PW; Deutch AY; Maggio JE; Mantyh PW; Roth RH
    Neurosci Lett; 1985 Jun; 57(3):241-6. PubMed ID: 2412193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of endogenous substance P in stress-induced activation of mesocortical dopamine neurones.
    Bannon MJ; Elliott PJ; Alpert JE; Goedert M; Iversen SD; Iversen LL
    Nature; 1983 Dec 22-1984 Jan 4; 306(5945):791-2. PubMed ID: 6197656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for, and nature of, the tonic inhibitory influence of habenulointerpeduncular pathways upon cerebral dopaminergic transmission in the rat.
    Nishikawa T; Fage D; Scatton B
    Brain Res; 1986 May; 373(1-2):324-36. PubMed ID: 2424555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmitter release from transplants of fetal ventral mesencephalon or locus coeruleus in the rat frontal cortex and nucleus accumbens: effects of pharmacological and behaviorally activating stimuli.
    Cenci MA; Kalén P; Duan WM; Björklund A
    Brain Res; 1994 Apr; 641(2):225-48. PubMed ID: 8012825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weaver mutation has differential effects on the dopamine-containing innervation of the limbic and nonlimbic striatum.
    Roffler-Tarlov S; Graybiel AM
    Nature; 1984 Jan 5-11; 307(5946):62-6. PubMed ID: 6690983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat.
    Hagan RM; Jones BJ; Jordan CC; Tyers MB
    Br J Pharmacol; 1990 Feb; 99(2):227-32. PubMed ID: 1691672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological evidence for non-dopaminergic mesocortical and mesolimbic neurons in the rat.
    Thierry AM; Deniau JM; Herve D; Chevalier G
    Brain Res; 1980 Nov; 201(1):210-4. PubMed ID: 7417833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of mesolimbic substance P systems to methamphetamine treatment.
    Hanson GR; Ritter JK; Schmidt CJ; Gibb JW
    Eur J Pharmacol; 1986 Sep; 128(3):265-8. PubMed ID: 2431914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area.
    Sesack SR; Pickel VM
    J Comp Neurol; 1992 Jun; 320(2):145-60. PubMed ID: 1377716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of noxious tail pinch on the discharge rate of mesocortical and mesolimbic dopamine neurons: selective activation of the mesocortical system.
    Mantz J; Thierry AM; Glowinski J
    Brain Res; 1989 Jan; 476(2):377-81. PubMed ID: 2702475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dopamine transporter and dopamine D2 receptor messenger RNAs are differentially expressed in limbic- and motor-related subpopulations of human mesencephalic neurons.
    Hurd YL; Pristupa ZB; Herman MM; Niznik HB; Kleinman JE
    Neuroscience; 1994 Nov; 63(2):357-62. PubMed ID: 7891851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential actions of dizocilpine (MK-801) on the mesolimbic and mesocortical dopamine systems: role of neuronal activity.
    Mathé JM; Nomikos GG; Blakeman KH; Svensson TH
    Neuropharmacology; 1999 Jan; 38(1):121-8. PubMed ID: 10193903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance K, a novel tachykinin injected bilaterally into the ventral tegmental area of rats increases behavioral response.
    Takano Y; Takeda Y; Yamada K; Kamiya H
    Life Sci; 1985 Dec; 37(26):2507-14. PubMed ID: 2417083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The place of dopamine in the cortico-basal ganglia circuit.
    Haber SN
    Neuroscience; 2014 Dec; 282():248-57. PubMed ID: 25445194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.